If enacted, New Jersey’s Medicaid agency would choose preferred drugs and other products by medical value and cost for payers to use in new, renewed, or changed agreements.
If enacted, New Jersey Medicaid payers would have to use a state list of preferred drugs and other products in agreements made, renewed, or changed once the law takes effect. Nonpreferred products would face extra rules.
New Jersey’s Medicaid agency would create and maintain a preferred list for Medicaid payers to use. The list would cover drugs and other products for Medicaid managed care plans and other Medicaid payers in New Jersey. The agency would choose preferred products based on medical value and cost. Any listed product could require advance approval, and nonpreferred products would have to meet extra list rules. The law would take effect on the first day of the seventh month following enactment. It would apply to contracts and agreements made, renewed, or changed on or after that day.
No hearings or votes scheduled.